Please note that only presentations that have been approved for sharing by their originators are available online.
Plenary Session I
PE/CT in Cancer Management
09.30 – 10.00
PET/CT and Molecular Imaging in Developing Countries Henry Bom, AOFNMB
10.00 – 10.30
The Burden of Cancer and the Role of Imaging Modalities Lale Umutlu, ESR
10.30 – 11.00
The Importance of PET/CT in Human Health Homer Macapinlac, MDACC, USA
11.00 – 11.30
PET/CT or PET/MR? Who Should PET Partner with? Thomas Beyer, EFOMP
11.30 – 12.00
Radiopharmaceuticals in Molecular Imaging Philip Elsinga, Netherlands
12.00 – 13.00
Lunch Break
Plenary Session II
Hybrid Imaging and Other Imaging Techniques in Breast Cancer
13.00 – 13.30
PET/CT Imaging in Breast Cancer Hossein Jadvar, SNMMI
13.30 – 14.00
Other Imaging Modalities in Breast Cancer Rathan Subramaniam, ACNM, USA
14.00 – 14.30
New Radiopharmaceutical Developments in Breast Cancer Jacek Koziorowski, Sweden
14.30 – 15.00
Read with the Expert: PET/CT, Breast Cancer Andrew Ross, CANM, Canada
Poster Review Session I
15.00 – 16.00
Meet-the-Authors: Poster Review (Thomas Pascual, IAEA)
Reviewers:
- Henry Bom, AOFNMB
- Homer Macapinlac, MDACC, USA
- Hossein Jadvar, SNMMI
- Rathan Subramaniam, ACNM, USA
- Andrew Ross, CANM, Canada
- Murat Fani Bozkurt, EANM
- Helen Nadel, Canada
- Sobhan Vinjamuri, BNMS, UK
- Akram Al-Ibraheem, ARSNM
Plenary Session III
Theranostics and Personalized Medicine
16.00 – 16.30
Imaging in Personalized Medicine Marcus Hacker, Austria
16.30 – 17.00
PET/CT Imaging / Theranostics Richard P. Baum, Germany
17.00 – 17.30
Radiopharmaceutical Aspects of the Theranostics in Neuroendocrine Tumours Vijay Kumar, ANZSNM
17.30 – 18.00
Read with the Expert: Radionuclide Therapies Richard P. Baum, German